Application study of the EQ-5D-5L in oncology: linking self-reported quality of life of patients with advanced or metastatic colorectal cancer to clinical data from a German tumor registry

Table 2 Mean EQ-5D-5L utility scores, the EQ-5D-5L VAS scores, and the EORTC global health status/QoL scores

	EQ-5D-5L Utility Score		EQ-5D-5L VAS Score		EORTC Global Health Status/ QoL Score
Time of questioning after enrollment	Mean	Standard Deviation (SD)	Mean	Standard Deviation (SD)	Mean	Standard Deviation (SD)
0 months	0.82	0.23	60.56	22.58	55.52	22.88
2 months	0.81	0.23	62.72	20.09	54.54	21.25
4 months	0.83	0.22	58.85	27.71	56.94	23.44
8 months	0.82	0.27	62.62	22.66	57.49	22.30
12 months	0.82	0.19	67.13	17.55	55.98	18.54
16 months	0.82	0.23	63.64	23.34	61.27	18.80
20 months	0.79	0.24	57.41	21.41	55.86	21.66
24 months	0.80	0.17	64.37	21.94	58.83	23.52
Overall	0.82	0.23	62.05	22.23	56.66	21.66

ISSN: 2191-1991